These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 37958342)
21. Expression of the Extracellular Sulfatase Yang Y; Ahn J; Raghunathan R; Kallakury BV; Davidson B; Kennedy ZB; Zaia J; Goldman R Front Oncol; 2020; 10():582827. PubMed ID: 33585200 [TBL] [Abstract][Full Text] [Related]
22. Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Morimoto-Tomita M; Uchimura K; Bistrup A; Lum DH; Egeblad M; Boudreau N; Werb Z; Rosen SD Neoplasia; 2005 Nov; 7(11):1001-10. PubMed ID: 16331886 [TBL] [Abstract][Full Text] [Related]
23. Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells. Johansson AC; Ansell A; Jerhammar F; Lindh MB; Grénman R; Munck-Wikland E; Östman A; Roberg K Mol Cancer Res; 2012 Sep; 10(9):1158-68. PubMed ID: 22809838 [TBL] [Abstract][Full Text] [Related]
24. Myeloid deficiency of heparan sulfate 6-O-endosulfatases impairs bone marrow hematopoiesis. Whitehead AK; Wang Z; Boustany RJ; Vivès RR; Lazartigues E; Liu J; Siggins RW; Yue X Matrix Biol; 2024 Dec; 134():107-118. PubMed ID: 39368561 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of cancer-associated fibroblasts and tumor-promoting roles in head and neck squamous cell carcinoma. El Herch I; Tornaas S; Dongre HN; Costea DE Front Mol Biosci; 2024; 11():1340024. PubMed ID: 38966131 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma. Allen JL; Hames RA; Mastroianni NM; Greenstein AE; Weed SA Oral Oncol; 2022 Sep; 132():106008. PubMed ID: 35803110 [TBL] [Abstract][Full Text] [Related]
27. Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma. Mito I; Takahashi H; Kawabata-Iwakawa R; Horikawa M; Ida S; Tada H; Matsuyama T; Misawa K; Takeda S; Chikamatsu K Oral Oncol; 2023 Jan; 136():106270. PubMed ID: 36462328 [TBL] [Abstract][Full Text] [Related]
28. Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate. Pempe EH; Burch TC; Law CJ; Liu J Glycobiology; 2012 Oct; 22(10):1353-62. PubMed ID: 22692045 [TBL] [Abstract][Full Text] [Related]
29. Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures. Essid N; Chambard JC; Elgaaïed AB Bosn J Basic Med Sci; 2018 Nov; 18(4):336-346. PubMed ID: 30172250 [TBL] [Abstract][Full Text] [Related]
30. Early stage mechanical remodeling of collagen surrounding head and neck squamous cell carcinoma spheroids correlates strongly with their invasion capability. Chen YQ; Kuo JC; Wei MT; Chen YC; Yang MH; Chiou A Acta Biomater; 2019 Jan; 84():280-292. PubMed ID: 30500449 [TBL] [Abstract][Full Text] [Related]
31. Differential Angiogenic Potential of 3-Dimension Spheroid of HNSCC Cells in Mouse Xenograft. Choi SY; Kang SH; Oh SY; Lee KY; Lee HJ; Gum S; Kwon TG; Kim JW; Lee ST; Hong YJ; Kim DG; Hong SH Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361027 [TBL] [Abstract][Full Text] [Related]
32. Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target. New J; Arnold L; Ananth M; Alvi S; Thornton M; Werner L; Tawfik O; Dai H; Shnayder Y; Kakarala K; Tsue TT; Girod DA; Ding WX; Anant S; Thomas SM Cancer Res; 2017 Dec; 77(23):6679-6691. PubMed ID: 28972076 [TBL] [Abstract][Full Text] [Related]
33. Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions. Le PN; Keysar SB; Miller B; Eagles JR; Chimed TS; Reisinger J; Gomez KE; Nieto C; Jackson BC; Somerset HL; Morton JJ; Wang XJ; Jimeno A Mol Carcinog; 2019 Mar; 58(3):398-410. PubMed ID: 30378175 [TBL] [Abstract][Full Text] [Related]
34. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528 [TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Takahashi H; Sakakura K; Kawabata-Iwakawa R; Rokudai S; Toyoda M; Nishiyama M; Chikamatsu K Cancer Immunol Immunother; 2015 Nov; 64(11):1407-17. PubMed ID: 26201938 [TBL] [Abstract][Full Text] [Related]
36. Hypoxic tumor-derived exosomal miR-21 induces cancer-associated fibroblast activation to promote head and neck squamous cell carcinoma metastasis. Ye B; Duan Y; Zhou M; Wang Y; Lai Q; Yue K; Cao J; Wu Y; Wang X; Jing C Cell Signal; 2023 Aug; 108():110725. PubMed ID: 37230199 [TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges. Hu C; Zhang Y; Wu C; Huang Q Cell Death Discov; 2023 Apr; 9(1):124. PubMed ID: 37055382 [TBL] [Abstract][Full Text] [Related]
39. Human Papillary and Reticular Fibroblasts Show Distinct Functions on Tumor Behavior in 3D-Organotypic Cultures Mimicking Melanoma and HNSCC. Wu S; Rietveld M; Hogervorst M; de Gruijl F; van der Burg S; Vermeer M; van Doorn R; Welters M; El Ghalbzouri A Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232952 [TBL] [Abstract][Full Text] [Related]
40. Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms. Mosca L; Minopoli M; Pagano M; Vitiello F; Carriero MV; Cacciapuoti G; Porcelli M Int J Oncol; 2020 May; 56(5):1212-1224. PubMed ID: 32319579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]